Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Induced Movement Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT02405091
What this trial is testing

Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 167
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Large-scale testing (Phase 3)Study completedNCT00190008
What this trial is testing

Piracetam for Treatment Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center 40
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Not applicableStudy completedNCT06060444
What this trial is testing

Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework

Who this might be right for
Drug-Induced Movement Disorder
University of Vermont 28
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Post-approval studies (Phase 4)Study completedNCT00114595
What this trial is testing

Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia

Who this might be right for
DyskinesiaSchizophrenia
University of Stellenbosch 84
Early research (Phase 1)Study completedNCT06216054
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

Who this might be right for
Tardive DyskinesiaHuntington Disease
Luye Pharma Group Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)WithdrawnNCT00621634
What this trial is testing

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Université de Montréal
Testing effectiveness (Phase 2)Study completedNCT01921270
What this trial is testing

Dysport for the Treatment of OMD

Who this might be right for
Oral DystoniaTardive Dystonia
Emory University 18
Not applicableNot Yet RecruitingNCT07505394
What this trial is testing

Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease

Who this might be right for
Parkinson DiseaseImpulse Control Disorder
Assistance Publique - Hôpitaux de Paris 528
Large-scale testing (Phase 3)Study completedNCT02291861
What this trial is testing

Addressing Involuntary Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 298
Testing effectiveness (Phase 2)Study completedNCT01688037
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 109
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Not applicableUnknownNCT06011408
What this trial is testing

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Who this might be right for
Tardive Dyskinesia
iRxReminder 300